| NewsFollowUp.com |
Plamegate at NFU |
Anthrax case at NFU |
NFU home | ||||||||
|
This page and site no longer updated on Bioport, please go to NewsFollowUp.com Bioport page
|
|||||||||||
|
Anthrax chronology |
Rove memo |
connections to: Bush White House, Franklin Scandal Omaha 1989 |
|||||||||
| Memo "April 25, 2001 ... memorandum for: Paul Wolfowitz ... from Karl Rove ... subject: Gulf War Syndrome and Anthrax ... Here is material which has been sent to me by Ross Perot regarding the Gulf War Syndrome, as well as some material on the Anthrax vaccine problem. .... I do think we need to examine the issues of both Gulf War Syndrome and the Anthrax vaccine and how they can be delt with. They are political problems for us. W00554 01" source: RawStory | |||||||||||
|
|||||||||||
| Dr. Bruce Ivins / Judith Miller top | ||||||||||||||
| PROGRESSIVE | REFERENCE | CONSERVATIVE | ||||||||||||
|
|
|
||||||||||||
|
||||||||||||||
|
||||||||||||||
| Timeline study on BioPort / Judith Miller / Anthrax / Fear Mongering | ||
|
source of above: Tetrahedon enlarge Timeline
|
Timeline
continued
|
|
|
Source: New York Times, August 5, 2002. and UCLA, Dept of Epidemiology, School of Public Health Anthrax Vaccine Maker Calls Finances Shaky By JUDITH MILLER LANSING, Mich., Aug. 1 -- The nation's sole producer of anthrax vaccine says it is in financial jeopardy because the Bush administration has failed to say how much vaccine it intends to buy, preventing it from selling vaccine to foreign and private customers at much higher prices. But the Pentagon has been unable to tell BioPort precisely how much more vaccine the government intends to order because several civilian agencies have not given the military budget commitments to pay for the vaccine they want, despite months of discussion. "Negotiations are ongoing and will be successful," a senior homeland security official said. "Sometimes talks go quickly; sometimes they don't." The anthrax vaccine is at the heart of the Bush administration's effort to protect American soldiers and civilians against another mass exposure to the deadly pathogen, which last fall killed 5 people, sickened about 17 and led more than 20,000 people to take antibiotics. The impasse comes at a time when the Bush administration is vowing to oust Saddam Hussein of Iraq, who is believed to be storing thousands of gallons of anthrax that could be used as weapons in war or terrorism. Senior BioPort executives disclosed that the Department of Defense is paying about $20 a dose for the vaccine, or more than three times the original price negotiated three years ago, and Pentagon officials confirmed this. But company officials say that even this price, while acceptable now, is too low to enable BioPort to make the long-term investments it needs to survive. "This company is a unique resource," Mr. Kramer said. "It's crazy for us as a business to risk our financial viability due to government indecision. Our long-term viability is at risk given the current situation." Bush administration officials say that they understand the company's predicament but that BioPort is partly responsible for it because of faulty business assumptions, repeated failures to meet requirements of the Food and Drug Administration and overly optimistic assumptions about its ability to produce vaccine. In June, for instance, the company threw out about 180,000 doses of vaccine it deemed substandard -- the equivalent of two weeks' production. In late June, the Pentagon announced a new anthrax vaccination policy, which reversed a plan by the Clinton administration to immunize all 2.4 million people in the military. The new policy limits vaccinations to soldiers in areas with a "higher risk" of exposure, widely reported to be the Middle East and the Korean peninsula. The policy also commits the administration to stockpiling for civilian use from 40 percent to half of the vaccine produced for the Pentagon. Soldiers are being vaccinated now, while civilians -- mostly police officers, firefighters, rescue crews and other "first responders" -- would receive shots only after exposure to anthrax. While BioPort says confusion exists in the government over how much vaccine should be ordered for both the military and civilians, some Bush administration officials blamed bureaucratic wrangling between civilian agencies and the Pentagon for the delay. The Department of Homeland Security, which is being created, is supposed to take charge of such orders, but in the interim the Defense Department has been coordinating orders of vaccine for itself and for several civilian agencies that want to stockpile the vaccine to protect government employees overseas, along with F.B.I. and other law enforcement agents, state and local emergency personnel and health workers. Providing immunity to the lethal anthrax spore is not easy. The Food and Drug Administration says that six shots given over 18 months and a yearly booster should be given to ensure protection. But new federal studies suggest that three shots of the vaccine may be enough, though the F.D.A. has not approved this. [Pentagon officials disclosed on Friday that 68,000 people on active duty in the military had received all six shots and that 440,000 had received at least two shots.] BioPort had been reluctant to discuss its protracted, often tense negotiations with the government, which officials attribute partly to the Michigan plant's well-documented production problems. The plant was renovated from 1999 to 2001 to meet the drug agency's standards. The military invested some $75 million in the renovations, but even after them, agency inspectors found many deficiencies that kept the plant from making new vaccine and releasing some 500,000 existing doses until late January. Some problems have lingered, such as the company's decision in June to discard 180,000 doses of vaccine that it called substandard. Mr. Kramer characterized the incident as a "nonevent" and "a normal part of the manufacturing process." The decision, he said, "had no impact on the production schedule and our ability to meet our obligation to the government." But Anna Johnson-Winegar, a civilian microbiologist for the Army who oversees some of the military's vaccine programs, said that the incident showed how tricky it was to estimate BioPort'sproduction capacity and to figure how much surplus the company might have for non-government customers. The company's production estimates, Dr. Johnson-Winegar said, "assumes that everything will go well." "It assume a perfect world," she said. Nevertheless, Dr. Johnson-Winegar expressed some sympathy for the company in its growing frustration with the pace of the government's negotiations. "They do need money for re-capitalization," she said. "But that's difficult since they are for the moment a one-product company with one customer." At the same time, other Pentagon officials complained, BioPort's financial predicament is partly the result of its own miscalculations. "They initially underestimated how much it would cost to produce product that could meet F.D.A. standards, or how much of their costs the State of Michigan, which once owned the plant, routinely picked up," one official said. The assumption that the company could turn a profit as the sole supplier of anthrax vaccine "may have been overly optimistic," the official said. BioPort was bought in 1998 for nearly $25 million by a group of private investors, including executives who had worked at the plant under Michigan ownership; Fuad El-Hibri; and Adm. William J. Crowe Jr., a former chairman of the Joint Chiefs of Staff. Many details of BioPort's contract and its production obligations are secret. But Pentagon officials said the company was permitted to sell up to 20 percent of its annual production after it produced the estimated 3.4 million doses that the Pentagon agreed to buy in 1999. While neither the government nor the company will say how much vaccine BioPort is producing, or its production capacity, Mr. Kramer said the government was "taking delivery of doses as fast as we can produce them." go to NFU Carlyle Group page
|
||
|
||
|
||
| Anthrax, Research Resouces top | |||
| PROGRESSIVE | REFERENCE | CONSERVATIVE | |
|
|
|
|
|
|||
| Judith Miller flow chart | |||
|
|
|||
| Bioport, Vaccinations, Court Martial top | ||
| PROGRESSIVE | REFERENCE | CONSERVATIVE* |
|
|
|
| INSLAW case murders |
|
Alan Standorf An employee of the National Security Agency in electronic intelligence. Standorf was a source of information for Danny Casalaro who was investigating INSLAW, BCCI, etc. Standorf's body was found in the backseat of a car at Washington National Airport on Jan 31, 1991. Etherzone 42inc NFU Jackson Stephens research Larry Guerrin Was killed in February 1987 while investigating the INSLAW case. Etherzone 42inc and NFU Jackson Stephens research Dennis Eisman An attorney with information on INSLAW. Eisman was found shot to death on April 5, 1991. Etherzone 42inc NFU Jackson Stephens research Ian Spiro Spiro had supporting documentation for grand jury proceedings on the INSLAW case. His wife and 3 children were found murdered on November 1, 1992 in their home. They all died of gunshot wounds to the head. Ian's body was found several days later in a parked car in the Borego Desert. Cause of death? The ingestion of cyanide. FBI report indicated that Ian had murdered his family and then committed suicide. Etherzone 42inc NFU Jackson Stephens research websites |
| Anthrax Mailings Inquiries Lead to Battelle/Bioport |
| Anthrax Mailings Inquiries Lead to Battelle/Bioport
By Ingri Cassel-208/265-2575; 800/336-9266 donavan posted this on
Sunday, January 27, 2002
Sandpoint, ID - Battelle Memorial Institute (BMI) is increasingly becoming the central suspect in the anthrax mailings investigation according to a growing number of independent investigators and newspapers initially tipped by a report released last Monday by Dr. Leonard G. Horowitz, a Harvard trained public health authority. The NY Times is the latest newspaper to include this West Jefferson, Ohio defense contractor that documents prove maintained close ties to the U.S. Army's Dugway "Life Sciences" center where the specific strain of anthrax was undergoing tests. The Baltimore Sun reported this week that, contrary to popular belief, the Defense Department maintained a potentially offensive biological weapons program using the Aimes strain of anthrax identified at Dugway. They failed to report that BMI largely administered and supplied this "Life Sciences" facility wherein a "virtually identical" strain of anthrax had been tested. After circulating his 20-page report (See: http://www.tetrahedron.org )to members congress and the press, Dr. Horowitz, the author of the prophetically titled book, "Death in the Air: Globalism, Terrorism and Toxic Warfare", contacted the William J. Broad, the anthrax mailings investigator for the New York Times, and co-author of "Germs", to discuss the accumulating evidence against BMI. "All roads lead to BMI," Broad agreed. Two days later, Broad and his co-author, Judith Miller, wrote that BMI "participated in a secret Central Intelligence Agency (CIA) program, code-named 'Clear Vision'" begun in 1997, that allegedly used benign substances similar to anthrax. The Horowitz report also argued that only someone with national security clearances, such as CIA operatives assigned to this top secret program, could have commandeered the anthrax from BMI to the mailings sites such as Trenton, New Jersey. He said, "CIA personnel are increasingly implicated in light of these revelations." Further implicating BMI and the CIA, both leading anthrax experts-America's William C. Patrick, III, and Russian defector, Kanatjan Alibekov-are BMI consultants and on the CIA's payroll, according to earlier published reports cited in the Horowitz report. "The whole truth would be severely embarrassing to the Bush administration," Dr. Horowitz said. "HHS Secretary Tommy Thompson has, after all, commandeered a bioterrorism preparedness drug feeding frenzy. With five persons killed and thirteen others infected so far, military-industrial officials may be implicated in serial homicide, if not economic genocide, while 'wagging the dog' for drug and vaccine company profits." Dr. Horowitz says that the Baltimore Sun report was highly significant regarding Dugway's "Life Sciences" Division. "'Death Sciences' seems to be a more accurate title for the lab largely developed, administered, and supplied by BMI where all roads appear to lead," Dr. Horowitz said. |
| excerpt from Centre for Research on Globalization, Propaganda Preparation for 9/11 |
|
Moreover,
there has been a widespread campaign on to link the threat of al-Qaida
with that of a mass biological attack. At least the day after September
11, the link - as the Anthrax mailings had yet to arise - was not so
apparent. Yet on PBS' Frontline, the New York Times' Judith Miller (no
apparent relation to John Miller, as far as I'm aware), accompanied by the
New York Times' James Risen, was interviewed as an expert on al-Qaida.
Several weeks later, Judith Miller would once more make the headlines as
the apparent recipient of an anthrax mailing which turned out to be a
false alarm - yet was all the same conveniently timed with the
well-publicized launching of her book on...germ warfare. As was later
discovered, the anthrax mailings petered out once the news leaked that a
DNA test revealed the material to be of the Ames strain of anthrax, an
agent synthesized out of a CIA laboratory in Fort Detrick, Maryland.
Nevertheless, this was sufficient to fast-track Bioport's exclusive
license for the anthrax vaccine toward FDA approval. Formerly, Bioport's
experimental anthrax vaccine was being forcibly administered - under
threat of court-martial - to hundreds of thousands of American servicemen
(in conformity with Bioport's exclusive and lucrative contract with the
Department of Defense). ......
Judith Miller, along with Jerry Hauer, was among 17 "key"
participants in a biowarfare exercise known as "Dark Winter" - a
think tank-funded scenario that aimed to study the nationwide effects of a
hypothetical smallpox outbreak. One
of the sponsors of that exercise was the Anser Institute of Homeland
Security, an organization established before September 11, 2001.
Interestingly enough, the curious phrase "homeland
security" was starting to creep up with increasing frequency in the
vocabularies of certain political cliques (Dick Cheney, the Hart-Rudman
Commission, et al.) in the year or two leading up to 9/11.
|
| Judith Miller, NY Times, August 2004, Anthrax article: |
| Wrangling Impedes Transfer Of Civilian Anthrax Vaccine LinkedinDiggFacebookMixxYahoo! By JUDITH MILLER Published: August 20, 2004 ...Despite pledges two years ago to maintain a stockpile of drugs to protect Americans in the event of a bioterrorism attack, the federal government has so far set aside only 159 vials of anthrax vaccine for the civilian population enough for only 530 people, according to congressional and administration officials. ... The officials said the failure to transfer more of the vaccine from military to civilian control was caused by legal and bureaucratic wrangling among government agencies. They also cited the government's desire to buy a new vaccine that is potentially both cheaper and more efficient. That vaccine has not yet been approved by the Food and Drug Administration. ... Spokesmen for the Pentagon and the Department of Health and Human Services denied that the delay would imperil the well-being of civilians, saying that BioPort, the nation's sole producer of licensed anthrax vaccine, was storing nearly a million doses -- enough for more than 330,000 people. ... ''The bottom line is: if there is a civilian crisis that would require vaccination of the population, there is enough anthrax vaccine to do that,'' said Bill Pierce, a spokesman for the Department of Health and Human Services. ''It would just take a phone call to get that vaccine transferred from the Pentagon to the stockpile,'' he said, dismissing the delays to ''paperwork that will get done.'' ... But a spokesman for BioPort and Pentagon officials said that the doses being stored are intended for the military, which announced in June that it was expanding its anthrax and smallpox vaccination program. If those doses were used by civilians in an emergency, officials said, military vaccinations would have to be curtailed or scaled back. ... Michael Zamiara, the chief financial officer of BioPort, in Lansing, Mich., said the military had first call on its vaccine. ''We must run a business,'' he said. While the Department of Health and Human Services had indicated it wanted the vaccine for the civilian stockpile, he said, the agency had yet to ''pay us for it, or tell us how much it wants to buy.'' ... Officials also said that the Bush administration had not implemented an interagency agreement signed last April, a copy of which was provided to The Times, in which the Pentagon agreed to provide at least two million doses of anthrax vaccine to the civilian stockpile by the end of this fiscal year, or Sept. 30. ... ''It is a shocking lack of preparedness to have only 159 vials set aside for civilian use when we know that Al Qaeda would not hesitate to launch an anthrax attack against the United States,'' said Rep. Jim Turner, Democrat of Texas, the ranking member of the House select committee on homeland security, which has been investigating the state of the nation's strategic stockpiles. ... Jerome Hauer, a former assistant secretary with the Department of Health and Human Services in the Bush administration, said the months of infighting over such issues as who would indemnify BioPort for its vaccine reflected a lack of priority on biodefense. ... ''We now have bureaucrats and lawyers running bioterrorism preparedness,'' said Mr. Hauer, who heads a biodefense center at George Washington University. ... The vaccine issue has been complicated by Congress's recent transfer of control of the civilian stockpile from the Department of Homeland Security back to the Department of Health and Human Services. ... Many scientists at the health agency favor a new recombinant vaccine that may require fewer shots and be faster to make. |
